PPDP study
T2DM
SECONDARY
The design and primary results of the PPDP study have been reported previously (Feces of the two groups before and after intervention were collected. The 16S rDNA sequencing technology was used to analyze intestinal microbiota’s structural composition and abundance changes. The primary outcome was the cumulative prevalence of T2DM in the two groups. The secondary endpoints were the possible changes in the proportion of microbiota. The study was registered in the Chinese clinical trial registry (ChiCTR-TRC-13004024).